Response to Hopkins, Kichenadasse, Logan, et al

Xinan Wang^{1

2}, Biagio Ricciuti³, Joao V Alessi³, Tom Nguyen³, Mark M Awad³, Xihong Lin⁴, Bruce E Johnson³, David C Christiani^{2

5}

Affiliations

¹ The Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA.
² Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
³ Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
⁴ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
⁵ Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.

PMID: 34450659
PMCID: PMC8902326
DOI: 10.1093/jnci/djab161

Comment

Response to Hopkins, Kichenadasse, Logan, et al

Xinan Wang et al. J Natl Cancer Inst. 2022.

. 2022 Mar 8;114(3):477-478.

doi: 10.1093/jnci/djab161.

Authors

Xinan Wang^{1

2}, Biagio Ricciuti³, Joao V Alessi³, Tom Nguyen³, Mark M Awad³, Xihong Lin⁴, Bruce E Johnson³, David C Christiani^{2

5}

Affiliations

¹ The Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA.
² Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
³ Lowe Center for Thoracic Oncology and Center for Cancer Genomics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
⁴ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
⁵ Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.

PMID: 34450659
PMCID: PMC8902326
DOI: 10.1093/jnci/djab161

No abstract available

PubMed Disclaimer

Comment in

RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.
Hopkins AM, Kichenadasse G, Logan JM, Rowland A, Sorich MJ. Hopkins AM, et al. J Natl Cancer Inst. 2022 Mar 8;114(3):475-476. doi: 10.1093/jnci/djab159. J Natl Cancer Inst. 2022. PMID: 34450652 Free PMC article. No abstract available.

Comment on

RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.
Hopkins AM, Kichenadasse G, Logan JM, Rowland A, Sorich MJ. Hopkins AM, et al. J Natl Cancer Inst. 2022 Mar 8;114(3):475-476. doi: 10.1093/jnci/djab159. J Natl Cancer Inst. 2022. PMID: 34450652 Free PMC article. No abstract available.

References

1. Hopkins AM, Kichenadasse G, Logan JM, Rowland A, Sorich MJ., Re: Smoking history as a potential predictor of immune checkpoint inhibitor efficacy in metastatic non-small cell lung cancer. J Natl Cancer Inst. 2022;114(3):475–476. - PMC - PubMed
1. Dai L, Jin B, Liu T, et al.The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: a systematic review and meta-analysis. EClinicalMedicine. 2021;38:100990. - PMC - PubMed
1. Mo J, Hu X, Gu L, et al.Smokers or non-smokers: Who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis. World J Surg Oncol. 2020;18(1):15. - PMC - PubMed
1. Wang X, Ricciuti B, Nguyen T, et al.Association between smoking history and tumor mutation burden in advanced non-small cell lung cancer. Cancer Res. 2021;81(9):2566–2573. - PMC - PubMed
1. Sheikh M, Mukeriya A, Shangina O, Brennan P, Zaridze D. Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: a prospective cohort study. Ann Intern Med. 2021. doi: 10.7326/M21-0252. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions

Grants and funding

U01 CA209414/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to Hopkins, Kichenadasse, Logan, et al

Affiliations

Response to Hopkins, Kichenadasse, Logan, et al

Authors

Affiliations

Comment in

Comment on

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources